FDA-cleared profile

TEX20/TEX20 Pro/TEX20S/TEX20T/TEX20 Exp/TEX20 Elite Diagnostic Ultrasound System, TEX10/ TEX10 Pro/TEX10S/TEX10T/TEX10 Exp/TEX10 Elite/TE X/TE X Lite Diagnostic Ultrasound System

Shenzhen Mindray Bio-Medical Electronics Co.,LTD · Ultrasound · FDA-cleared (510(k))

Authorized purpose: The TEX20, TEX10, TE X, and TE X Lite family provides mobile diagnostic ultrasound across broad adult, obstetric, pediatric, and neonatal applications; K212265 includes AI-based Smart Nerve visualization for interscalene and supraclavicular brachial plexus scouting, not live interventional guidance.

Clinical role
General and point-of-care ultrasound acquisition, measurement, analysis, and supported nerve visualization.
Images and patients
Ultrasound · Multi-region
Key limitation
Keep in mind: Smart Nerve is used to recognize the interscalene and supraclavicular brachial plexus. It is intended for visualization purpose only and not intended for live guidance during interventional procedure.

Overview status: Source-reviewed overview

Report a correction
Clinical details Purpose, workflow fit, evidence, and safety record

Workflow navigation pilot

Workflow role has not yet been reviewed for this navigation pilot.

A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources

  • What does this software do?Authorized purpose: The TEX20, TEX10, TE X, and TE X Lite family provides mobile diagnostic ultrasound across broad adult, obstetric, pediatric, and neonatal applications; K212265 includes AI-based Smart Nerve visualization for interscalene and supraclavicular brachial plexus scouting, not live interventional guidance.
  • Which images or clinical context are in scope?Modality: Ultrasound Anatomy or clinical context: Multi-region Input: Ultrasound image data and real-time data from a bedside device through X-Link.
  • Who uses it?Intended users: Competent healthcare professionals.
  • What does the software produce?Output: Ultrasound images, measurements of anatomical structures, analysis packages, and Smart Nerve visualization.
  • What is its most important limitation?Key limitation: Smart Nerve is used to recognize the interscalene and supraclavicular brachial plexus. It is intended for visualization purpose only and not intended for live guidance during interventional procedure.

Clinical takeaway. Clinical role: The TEX20, TEX10, TE X, and TE X Lite family provides mobile diagnostic ultrasound across broad adult, obstetric, pediatric, and neonatal applications; K212265 includes AI-based Smart Nerve visualization for interscalene and supraclavicular brachial plexus scouting, not live interventional guidance.

Evidence takeaway. Evidence from the reviewed source record: K212265 reports acoustic-output, biocompatibility, cleaning, electrical, mechanical, software, usability, and risk-management testing. The FDA summary identifies Smart Nerve as an AI feature but does not disclose a clinical dataset or numerical accuracy results.

Evidence context

Evidence context not reviewed for this FDA record.

Public-label constraints

Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.

Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.

Purpose
The TEX20, TEX10, TE X, and TE X Lite family provides mobile diagnostic ultrasound across broad adult, obstetric, pediatric, and neonatal applications; K212265 includes AI-based Smart Nerve visualization for interscalene and supraclavicular brachial plexus scouting, not live interventional guidance.
  • Exact FDA submission
  • Checked 2026-09-19

Clinical-use display mirrors the exact FDA-supported purpose reconciled from the decision-summary packet.

Workflow role
General and point-of-care ultrasound acquisition, measurement, analysis, and supported nerve visualization.
  • Exact FDA submission
  • Checked 2026-09-03
Required input
Ultrasound image data and real-time data from a bedside device through X-Link.
  • Exact FDA submission
  • Checked 2026-09-19

The exact packet supports ultrasound image data and bedside-device data through X-Link, but does not state the prior wired-or-wireless probe wording.

Output and clinician action
Ultrasound images, measurements of anatomical structures, analysis packages, and Smart Nerve visualization.
  • Exact FDA submission
  • Checked 2026-09-19

The exact packet supports image display, anatomical measurements, analysis packages, and Smart Nerve visualization; it does not state reports as an output.

Care setting
Hospitals, clinics, operating rooms, emergency, anesthesia, critical-care, and other supported diagnostic environments.
  • Exact FDA submission
  • Checked 2026-09-03
Intended users
Competent healthcare professionals.
  • Exact FDA submission
  • Checked 2026-09-19

The exact packet names competent healthcare professionals but does not establish the dossier's more specific role list.

Limitations
Smart Nerve is used to recognize the interscalene and supraclavicular brachial plexus. It is intended for visualization purpose only and not intended for live guidance during interventional procedure.
  • Exact FDA submission
  • Checked 2026-09-19

This replaces the dossier's additional later-release qualification with the exact Smart Nerve boundary in the packet.

Evidence summary
K212265 reports acoustic-output, biocompatibility, cleaning, electrical, mechanical, software, usability, and risk-management testing. The FDA summary identifies Smart Nerve as an AI feature but does not disclose a clinical dataset or numerical accuracy results.
  • Exact FDA submission
  • Checked 2026-09-03

Evidence

Performance evidence

Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.

Evidence summary
K212265 reports acoustic-output, biocompatibility, cleaning, electrical, mechanical, software, usability, and risk-management testing. The FDA summary identifies Smart Nerve as an AI feature but does not disclose a clinical dataset or numerical accuracy results.
  • Public source
  • Exact FDA submission
  • Checked 2026-09-03
Reported sensitivity
Not applicable
  • Not applicable
  • Not applicable
  • Checked 2026-09-03

Sensitivity is not the primary applicable endpoint for this acquisition, reconstruction, segmentation, planning, guidance, or quantitative-biomarker function. Use the task-specific endpoints and tested population reported below.

Reported specificity
Not applicable
  • Not applicable
  • Not applicable
  • Checked 2026-09-03

Specificity is not the primary applicable endpoint for this acquisition, reconstruction, segmentation, planning, guidance, or quantitative-biomarker function. Use the task-specific endpoints and tested population reported below.

No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.

K212265 FDA performance package for TEX20/TEX20 Pro/TEX20S/TEX20T/TEX20 Exp/TEX20 Elite Diagnostic Ultrasound System, TEX10/ TEX10 Pro/TEX10S/TEX10T/TEX10 Exp/TEX10 Elite/TE X/TE X Lite Diagnostic Ultrasound System

  • DesignManufacturer nonclinical system, software, acoustic-output, probe, safety, and usability verification
  • PopulationRepresentative adult, obstetric, pediatric, neonatal, and procedural ultrasound use conditions
  • Scopeexact submission
  • Tested versionTEX20/TEX10/TE X family release cleared in K212265
  • IndependenceSponsor or vendor study

K212265

Manufacturer evidence submitted for substantial equivalence; local clinical, technical, and workflow acceptance remains necessary.

Safety and lifecycle

Postmarket record

Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.

Postmarket safety review
The 2026-09-02 openFDA device-recall snapshot contained no record matched to K212265 by exact submission identifier.
  • Public source
  • Exact FDA submission
  • Checked 2026-09-03

A zero-result exact-identifier search does not prove that no recall, correction, adverse-event report, or product-family safety signal exists.

Pricing & contracts Public price, contract terms, and reimbursement

Price not public here; enter your quote

Not publicly available: Reviewed sources do not publish an exact-product procurement price with a stated offer scope.

Reimbursement

Reimbursement
No separate named-product Medicare payment was identified in the reviewed CMS coverage material. Evaluate the device within the applicable imaging or surgical service line and verify payer, site-of-service, and coding assumptions independently.
  • Service-level, not product-specific
  • Checked 2026-09-03

No product-specific code

No separate named-product payment identified in reviewed public material

Centers for Medicare & Medicaid Services · United States

Build a local total-cost and value model; do not infer reimbursement from FDA clearance.

IT implementation Deployment, interfaces, data handling, and support

System and version relationships

Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.

No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.

Review Merge, Visage, Sectra, AGFA and IntelePACS context

Integration chain: evidence at each hop

Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.

Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner

No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.

  1. Acquisition/source

    Source context, not route validation: Ultrasound image data and real-time data from a bedside device through X-Link.

    Scope: Exact FDA submission. The exact packet supports ultrasound image data and bedside-device data through X-Link, but does not state the prior wired-or-wireless probe wording.

    Confirm scanner/model, protocol, series completeness and both software builds.

    Field checked 2026-09-19 · FDA K212265: TEX20/TEX20 Pro/TEX20S/TEX20T/TEX20 Exp/TEX20 Elite Diagnostic Ultrasound System, TEX10/ TEX10 Pro/TEX10S/TEX10T/TEX10 Exp/TEX10 Elite/TE X/TE X Lite Diagnostic Ultrasound System

  2. Routing

    Source context, not route validation: DICOM ultrasound workflow, X-Link bedside-device data matching, optional wireless probe charging, and voice control; validate patient matching, timing, device compatibility, archive, probes, and local infection-control workflow.

    Scope: Exact FDA submission.

    Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.

    Field checked 2026-09-03 · FDA K212265: TEX20/TEX20 Pro/TEX20S/TEX20T/TEX20 Exp/TEX20 Elite Diagnostic Ultrasound System, TEX10/ TEX10 Pro/TEX10S/TEX10T/TEX10 Exp/TEX10 Elite/TE X/TE X Lite Diagnostic Ultrasound System · TEX20 point-of-care ultrasound system

  3. AI processing

    Source context, not route validation: Mobile ultrasound console with supported probes, options, network interfaces, and accessories.

    Scope: Exact FDA submission.

    Confirm processing location, queue ownership, exclusions and exact AI build.

    Field checked 2026-09-03 · FDA K212265: TEX20/TEX20 Pro/TEX20S/TEX20T/TEX20 Exp/TEX20 Elite Diagnostic Ultrasound System, TEX10/ TEX10 Pro/TEX10S/TEX10T/TEX10 Exp/TEX10 Elite/TE X/TE X Lite Diagnostic Ultrasound System · TEX20 point-of-care ultrasound system

  4. Returned objects

    Source context, not route validation: Ultrasound images, measurements of anatomical structures, analysis packages, and Smart Nerve visualization.

    Scope: Exact FDA submission. The exact packet supports image display, anatomical measurements, analysis packages, and Smart Nerve visualization; it does not state reports as an output.

    Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.

    Field checked 2026-09-19 · FDA K212265: TEX20/TEX20 Pro/TEX20S/TEX20T/TEX20 Exp/TEX20 Elite Diagnostic Ultrasound System, TEX10/ TEX10 Pro/TEX10S/TEX10T/TEX10 Exp/TEX10 Elite/TE X/TE X Lite Diagnostic Ultrasound System

  5. Viewer/worklist/report

    Unresolved route: Ultrasound images, measurements of anatomical structures, analysis packages, and Smart Nerve visualization.

    Scope: Exact FDA submission. The exact packet supports image display, anatomical measurements, analysis packages, and Smart Nerve visualization; it does not state reports as an output.

    Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.

    Field checked 2026-09-19 · FDA K212265: TEX20/TEX20 Pro/TEX20S/TEX20T/TEX20 Exp/TEX20 Elite Diagnostic Ultrasound System, TEX10/ TEX10 Pro/TEX10S/TEX10T/TEX10 Exp/TEX10 Elite/TE X/TE X Lite Diagnostic Ultrasound System

  6. Support owner

    Unresolved route: Not established for the exact route.

    Scope: Scope not established.

    Name the local, platform and AI supplier support owners and escalation path.

Planned local route tests

No tests below have been performed or accepted.

  1. Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
  2. Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
  3. Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
  4. Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
  5. Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
  6. Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
  7. Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.

Local implementation checklist

Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.

Open the printable evaluation checklist

Deployment
Mobile ultrasound console with supported probes, options, network interfaces, and accessories.
  • Exact FDA submission
  • Checked 2026-09-03
Integration
DICOM ultrasound workflow, X-Link bedside-device data matching, optional wireless probe charging, and voice control; validate patient matching, timing, device compatibility, archive, probes, and local infection-control workflow.
  • Exact FDA submission
  • Checked 2026-09-03
Security
Mindray's Product Cybersecurity Whitepaper (November 2024) describes a product cybersecurity model for its devices covering governance and risk management, secure design and development (secure coding, security assessment and testing), protective measures (access control, system hardening), post-market vulnerability and patch management, incident logging and response, and data protection including data encryption and privacy impact assessment.
  • Vendor-wide
  • Checked 2026-10-27

Vendor whitepaper describing practices across Mindray products generally; no per-product annex read for the TEX20 series. Exact-release scope is not established.

Training
Only competent physicians, sonographers, anesthesiology and critical-care clinicians, and trained ultrasound professionals. should operate or interpret the system. Local onboarding should cover the exact release, supported population, limitations, failure examples, escalation, downtime, and competency documentation.
  • Exact FDA submission
  • Checked 2026-09-03
Monitoring
Monitor by exact hardware, software and model version, patient population, anatomy, protocol, operator, input quality, output edits or overrides, failed studies, repeat acquisition or rework, downstream impact, downtime, incidents, recalls, and updates. Track the limits that matter for this product: Smart Nerve is limited to recognizing interscalene and supraclavicular brachial plexus for visualization and is not intended for live guidance during an intervention. Later TEX20 product-family features must not be attributed to K212265 without version mapping.
  • Exact FDA submission
  • Checked 2026-09-03

Release and scope verification

Map the installed model, build, options, population, anatomy, inputs, and outputs to K212265 before acceptance.

exact submission · checked 2026-09-03

Later product-family features are not evidence that this cleared release includes them.

Interoperability acceptance

DICOM ultrasound workflow, X-Link bedside-device data matching, optional wireless probe charging, and voice control; validate patient matching, timing, device compatibility, archive, probes, and local infection-control workflow.

exact submission · checked 2026-09-03

Test representative identifiers, orientation, geometry, measurements, units, routing, failure handling, and round trips locally.

Clinical acceptance

Use a signed local test set for the supported population and workflow. Include common and difficult cases, exclusions, acquisition variation, failed or low-quality inputs, reviewer overrides, and downstream effects. Smart Nerve is limited to recognizing interscalene and supraclavicular brachial plexus for visualization and is not intended for live guidance during an intervention. Later TEX20 product-family features must not be attributed to K212265 without version mapping.

exact submission · checked 2026-09-03

Define stop-use, escalation, rollback, and revalidation triggers before production use.

Economic evaluation

Model capital and recurring cost against net staff time after review, throughput, repeat imaging or rework, room time, consumables, infrastructure, training, service, downtime, upgrade, and replacement costs.

product family · checked 2026-09-03

Vendor productivity claims are scenario inputs, not guaranteed local savings.

Lifecycle monitoring

Monitor by exact hardware, software and model version, patient population, anatomy, protocol, operator, input quality, output edits or overrides, failed studies, repeat acquisition or rework, downstream impact, downtime, incidents, recalls, and updates. Track the limits that matter for this product: Smart Nerve is limited to recognizing interscalene and supraclavicular brachial plexus for visualization and is not intended for live guidance during an intervention. Later TEX20 product-family features must not be attributed to K212265 without version mapping.

exact submission · checked 2026-09-03

Revalidate after material software, hardware, model, protocol, interface, or clinical-policy changes.

Sources & review details FDA identity, research record, source ledger, and history

Regulatory identity

FDA record and catalog context

The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.

FDA submission
K212265
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Modality
Ultrasound
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-19

Exact FDA decision-summary packet reviewed on 2026-09-19; existing wording is supported without expansion.

Anatomy
Multi-region
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-19

Exact FDA decision-summary packet reviewed on 2026-09-19; existing wording is supported without expansion.

Clearance type
510(k)
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Decision date
2021-11-16
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
FDA status
FDA-cleared
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31

Research record

What has been checked

This audit distinguishes completed source review from fields that have not yet been researched.

Exact FDA record reviewedStatus
2026-09-20Last searched
27Fields reviewed
11Source classes checked
20Screened PubMed leads
0Screened trial leads
0Unreviewed FDA recall leads

The refreshed discovery snapshot contains 20 PubMed and 0 ClinicalTrials.gov candidate records. Discovery metadata alone does not establish exact tested-product, version, population, and endpoint applicability, so all candidates remain quarantined and none was promoted. The current discovery snapshot contains 20 PubMed and 0 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.

Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.

Source classes: fda ai list, fda decision summary, vendor product page, reimbursement policy, fda device recall, fda decision summary packet, literature index, trial registry, pubmed, clinical trials, openfda device recall

Field review details

Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.

  • Public pricing: Not publicly available - checked 2026-09-03 - Exact FDA submission

    No public list price for the exact cleared configuration was found. Obtain a written quote separating hardware or license basis, enabled features, implementation, interfaces, infrastructure, training, service, upgrades, renewal, consumables, and exit costs.

  • Pricing model: Not yet reviewed
  • Setup and integration fees: Not yet reviewed
  • Recurring fees: Not yet reviewed
  • Minimum commitment: Not yet reviewed
  • Contract duration: Not yet reviewed
  • Renewal terms: Not yet reviewed
  • Cancellation terms: Not yet reviewed
  • Support and service terms: Not yet reviewed
  • Trial or pilot terms: Not yet reviewed
  • Data hosting location: Not yet reviewed
  • Data retention: Not yet reviewed
  • Documented data use: Not yet reviewed
  • Hardware requirements: Not yet reviewed
  • Network requirements: Not yet reviewed
  • Identity and access: Not yet reviewed
  • Installation timeline: Not yet reviewed

8 sources - 3 history items

Source ledger

  1. FDA K212265: TEX20/TEX20 Pro/TEX20S/TEX20T/TEX20 Exp/TEX20 Elite Diagnostic Ultrasound System, TEX10/ TEX10 Pro/TEX10S/TEX10T/TEX10 Exp/TEX10 Elite/TE X/TE X Lite Diagnostic Ultrasound System

    U.S. Food and Drug Administration - Published 2021-11-16 - Accessed 2026-09-19

    Scope: purpose, modality, anatomy, intendedUsers, input, output, limitations, evidenceSummary, clinicalUse

  2. Artificial Intelligence-Enabled Medical Devices

    U.S. Food and Drug Administration - Accessed 2026-08-31

    Scope: regulatoryIdentity, modalityContext

  3. PubMed biomedical literature index

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery

  4. ClinicalTrials.gov study registry

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery, studyStatus

  5. Medicare Coverage Database

    Centers for Medicare & Medicaid Services - Accessed 2026-09-01

    Scope: coverage, codingContext

  6. openFDA Device Recall API

    U.S. Food and Drug Administration - Accessed 2026-09-02

    Scope: recallDiscovery, nativeSubmissionMatching

  7. TEX20 point-of-care ultrasound system

    Mindray - Accessed 2026-09-03

    Scope: productFamily, workflowRole, training, implementationCapabilities, currentCommercialContext

  8. Mindray: Product Cybersecurity Whitepaper

    Mindray - Accessed 2026-10-27

    Scope: security

Research history

  1. K212265 FDA decision

    Regulatory record

    510(k)

  2. Source-review record updated

    Research record

    fda record reviewed

  3. Reader overview source-reviewed

    Editorial review

    Source-reviewed editorial overlay

Alternatives

Related tools to compare

FDA-cleared K252074

Aplio i900, Aplio i800 and Aplio i700 Software V9.0 Diagnostic Ultrasound System

Canon Medical Systems Corporation

Authorized purpose: Aplio i900, i800, and i700 software V9.0 are mobile diagnostic ultrasound systems for multi-region imaging. K252074 adds deep-learning 3rd Harmonic Imaging for abdominal images; with specified endoscopic transducers, the Aplio i800/E3 also supports imaging of the upper gastrointestinal tract, surrounding organs, airways, tracheobronchial tree, and esophagus.

Modality
Ultrasound
Anatomy
Multi-region
Decision
2025-10-31
FDA-cleared K251963

LOGIQ E10s

Ge Medical Systems Ultrasound and Primary Care Diagnostics

Authorized purpose: LOGIQ E10s is a general-purpose diagnostic ultrasound system supporting the labeled adult, pediatric, cardiac, vascular, abdominal, obstetric, small-organ, musculoskeletal, urologic, and procedural applications.

Modality
Ultrasound
Anatomy
Multi-region
Decision
2025-10-29
FDA-cleared K251985

LOGIQ E10

Ge Medical Systems Ultrasound and Primary Care Diagnostics

Authorized purpose: LOGIQ E10 is a general diagnostic ultrasound system for qualified users across fetal and obstetric, abdominal, gynecologic, pediatric, small-organ, breast, cardiac, vascular, musculoskeletal, urologic, transrectal, transvaginal, transesophageal, and intraoperative applications.

Modality
Ultrasound
Anatomy
Multi-region
Decision
2025-10-29

Correct this exact record

Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.

Open existing correction destination

Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.

Accepted repository change history

No entry has been added to this scoped change history for this record. This is not proof that the record never changed.

Correction policy and limits · Public repository change history